Comparison Chart Corbus Pharmaceuticals Holdings, Inc.
Stocks
CRBP
US21833P3010
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 8.240 USD | -7.00% |
|
-28.10% | +1.23% |
| 08-13 | Mizuho Adjusts PT on Corbus Pharmaceuticals to $33 From $34, Keeps Outperform Rating | MT |
| 08-07 | Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $48 From $52, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Bio Therapeutic Drugs | -7.00% | -28.10% | +1.23% | -14.70% | -76.92% | 171M |  |  | |
- Stock Market
- Stocks
- CRBP Stock
- Charts Corbus Pharmaceuticals Holdings, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
